See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

ARKRAY introduces The GLUCOCARD™ X-METER

Becky Brown

ARKRAY introduces The GLUCOCARD™ X-METER

New Small Molecule Drugs for Type 2 - Human Trials Underway

Christoph Westphal, MD, Ph.D

New Small Molecule Drugs for Type 2 - Human Trials Underway

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

type 2 diabetes

Updated 3 hours ago
Ethnic Stereotypes May Contribute To Obesity
Sep 22, 2014 | 
The negative impact of ethnic stereotypes may also contribute to obesity – and related illnesses - among minorities, according to a new study.
Bollywood Dancing- An Effective Weapon Against Type 2 Diabetes
Sep 20, 2014 | 
CURE-D is the first Bollywood dance research and intervention study designed for South Asian immigrants in the United States. Success with Zumba and Latin hip-hop to manage diabetes in other populations contributed to this study.
DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

ARKRAY introduces The GLUCOCARD™ X-METER

Becky Brown

ARKRAY introduces The GLUCOCARD™ X-METER

New Small Molecule Drugs for Type 2 - Human Trials Underway

Christoph Westphal, MD, Ph.D

New Small Molecule Drugs for Type 2 - Human Trials Underway

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

Study Ties Earlier Onset Of Type 2 To More Complications
Sep 17, 2014 | 
A study from the Joint Asia Diabetes Evaluation shows that the age when a person is diagnosed with type 2 may have an effect on the complications that person later experiences. Interestingly, the study suggests a reason for the likelihood of more complications despite being younger is tied into the use of statins.
CDC Predicts 40% of American Adults Will Develop Diabetes
Sep 15, 2014 | 
Based on a statistical analysis of almost 600,000 American Adults in three studies, the Centers for Disease Control estimates that 40 percent of all U.S. adults 20 years or older will develop type 2 diabetes in their lives. (The risk for men was estimated at 40.2 percent and for women, 39.6 percent.)For Hispanic men and women and non-Hispanic black women, the statistical risk is higher: more than 50 percent.
Study Shows New Wound Care Technology
Sep 6, 2014 | 
A new wound-care dressing developed by a California firm has been shown to not only reduce the cost of treating wounds, but also to improve the outcomes of those treatments.

That’s good news for diabetics. According to statistics, about 15 percent of those with the disease develop chronic wounds – most often foot ulcers – that can result in amputation.

The was study, conducted at the Southwest Regional Wound Care Center in Lubbock, Texas. They found, Enluxtra Any Wound dressing developed by OSNovative Systems, Inc., reduced medical costs of chronic wound care by 30 percent. In part because it replaces many different products. Including primary foam, the gelling agent alginate, hydrogel dressings, hydro-conductive fiber, super-absorbent collagen, opaque dressing, hydrocolloid, gauze and combination dressings.

Any Wound dressing, crafted of FDA-approved polymers, is designed to sense and accommodate the different parts of the wound that need hydration or absorption, and a single dressing can remain in place for up to seven days.
Eylea Earns FDA Approval To Treat Diabetic Macular Edema
Sep 3, 2014 | 
The U.S. Food and Drug Administration has approved the eye drug Eylea for the treatment of diabetic macular edema, according to the drug makers Regeneron Pharmaceuticals, Inc.
Genteel: A Pain Free Lancing Instrument
Aug 22, 2014 | 
All Dr. Christopher Jacobs’ friend wanted a lancing device that didn’t cause pain.  And after hearing the longtime type 1 diabetic lament the discomfort he felt from the many finger pricks required to test his blood glucose levels, Jacobs was intrigued by the challenge.
Next Page »  
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.